Quality by design (QbD) approaches for the compression step of tableting

Expert Opinion on Drug Delivery

Volumn 8, Issue 12, 2011, Pages 1631-1644

  Tho, Ingunn ^a   Bauer Brandl, Annette ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Direct compression; Mechanical properties; Modeling; Multivariate analysis; Parameterization; Particle properties; Prediction; Tablet

Indexed keywords

EXCIPIENT; LACTOSE; MICROCRYSTALLINE CELLULOSE;

CRYSTAL STRUCTURE; CRYSTALLIZATION; DENSITY; DILUTION; DISCRIMINANT ANALYSIS; DRUG DESIGN; DRUG QUALITY; DRUG RELEASE; DRUG SCREENING; DRUG UPTAKE; FRAGMENTATION REACTION; LUBRICATION; MOISTURE; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; REVIEW; SIMULATION; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET HARDNESS; TABLET MANUFACTURE; TABLET POROSITY; TABLET PROPERTY; TABLET SURFACE; TENSILE STRENGTH;

DRUG COMPOUNDING; PRESSURE; TABLETS; TENSILE STRENGTH;

EID: 81855228060     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.633506     Document Type: Review

References (95)

1. Process analytical Technology - (PAT) Initiative. Available from: http://www. fda.gov/About FDA/Centers Offices/ CDER/ucm0 88828.htm [Last accessed 30 March 2011]
2. Guidance for Industry; PAT -A Framework for innovative pharmaceutical manufacturing and quality assurance, 2004. Available from: www.fda.gov/ downloads/Drugs/ Guidance Compliance Regulatory Information/Guidances/UCM070305. pdf [Last accessed 30 March 2011]
3. Yu LX. Pharmaceutical quality by design: product and process development, understanding and control. Pharm Res 2008;25:781-91
4. Rajalahti T, Kvalheim OM. Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm 2011;417:280-90
5. Guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Q8. Available from: http://www.ich.org/ fileadmin/Public-Web-Site/ ICH-Products/Guidelines/ Quality/ Q8-R1/Step4/Q8-R2-Guideline.pdf [Last accessed 30 March 2011]
6. Guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICI Q9. Available from: http://www.ich. org/fileadmin/Public-Web-Site/ ICH-Products/Guidelines/ Quality/ Q9/Step4/Q9-Guideline.pdf [Last accessed 30 March 2011]
7. Guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Q10. Available from: http://www.ich.org/ fileadmin/Public-Web-Site/ ICH-Products/Guidelines/Quality/Q10/ Step4/Q10-Guideline.pdf [Last accessed 30 March 2011]
8. Geoffroy J-M, Rivkees D. Pharmaceutical manufacturing: changes in paradigms. In: Augsburger LL, Hoag SW, editors. Pharmaceutical dosage forms: tablets. 3rd edition. Volume 3 Informa Healthcare; New York: 2008
9. Kourti T. The Process analytical technology initiative and multivariate process analysis, monitoring and control. Anal Bioanal Chem 2006;384:1043-8 (Pubitemid 43333984)
10. Leuenberger H, Lanz M. Pharmaceutical powder technology -from art to science: the challenge of the FDÁs process analytical technology initiative. Adv Powder Technol 2005;16:3-25 (Pubitemid 40416461)
11. European Pharmacopeia 7.0 2011, Monograph 5.15. Functionality-related characteristics of excipients; p.661
12. Sun C, Grant DJW. Influence of crystal structure on the tabletig properties of sulfamerazin polymorphs. Pharm Res 2001;18:274-80 (Pubitemid 32595813)
13. Sun C, Grant DJW. Influence of crystal shape on the tableting performance of L-Lysine monohyhrochloride dehydrate. J Pharm Sci 2001;90:569-79 (Pubitemid 32378378)
14. Sonnergaard JM. A critical evaluation of the Heckel equation. Int J Pharm 1999;193:63-71
15. Albers J, Knop K, Kleinebudde P. Brand-to-brand and batch-to-batch uniformity of microcrystalline cellulose in direct tableting with a pneumohydraulic tablet press. Pharm Ind 2006;68(12):1420-8 (Pubitemid 46338091)
16. Neuhaus T. Investigation and optimisation of the Presster - A linear compaction simulator for rotary tablet presses, Ph D thesis, University of Bonn, Germany. Available from: http://hss.ulb. uni-bonn.de/2007/1152/1152.pdf [Last accessed 30 March 2011]
17. Michaut F, Busignies V, Fouquereau C, et al. Evaluation of a rotary tablet press simulator as a tool for the characterization of compaction properties of pharmaceutical products. J Pharm Sci 2010;99(6):2874-85
18. Hiestand EN, Wells JE, Peot CB, Ochs JF. Physical processes oftableting. J Pharm Sci 1977;66:510-19
19. Bauer-Brandl A, Ritschel WA. Die tablette: Handbuch der Entwicklung, Herstellung und Qualitatssicherung. Chapter 5. Komprimieren. 3rd edition. Editio Cantor Verlag; Aulendorf: 2002 23.
20. Seth PL, Speiser P. Physikalisch-technische Aspekte der Tablettierung. Pharm Acta Helv 1966;41:385-404
21. Shotton E. The compression ofpowders. Pharm Ind 1972;34:256-62
22. Shotton E, Ganderton D. The strength of compressed tablets. J Pharm Pharmacol 1961;13(Suppl):144T-51T
23. Alderborn G, Nystrom C. Studies on direct compression of tablets. IV. The effect of particle size on the mechanical strength of tablets. Acta Pharm Suec 1982;19(5):381-91
24. Fichtner F, Rasmuson AC, Aalander EM, Alderborn G. Effect of preparation method on compactability of paracetamol granules and agglomerates. Int J Pharm 2007;336:148-58 (Pubitemid 46551565)
25. Fichtner F, Mahlin D, Welch K, et al. Effect of surface energy on powder compactibility. Pharm Res 2008;25:2750-9
26. Jetzer W, Leuenberger H. Compression characteristics of sodium chloride, potassium chloride and hexamethylenetetramine. Powder Technol 1985;42:137
27. Patel S, Kaushal AM, Bansai AK. Mechanistic investigation on pressure dependency of Heckel parameter. Int J Pharm 2010;389:66-73
28. Herting MG, Kleinebudde P. Studies on the reduction of tensile strength of tablets after roll compaction/dry granulation. Eur J Pharm Biopharm 2008;70(1):372-9
29. Farber L, Hapgood KP, Michaels JN, et al. Unified compaction curve model for tensile strength of tablets made by roller compaction and direct compression. Int J Pharm 2008;346(1-2):17-24 (Pubitemid 350101988)
30. Kuntz T, Schubert MA, Kleinebudde P. Increased compactibility of acetames after roll compaction. Eur J Pharm Biopharm 2011;77(1):164-9
31. Sun CC. On the mechanism of reduced tabletability of granules prepared by roller compaction. Int J Pharm 2008;47(1-2):171-2 (Pubitemid 350180329)
32. Nordstrom J, Klevan I, Alderborn G. A particle rearrangement index based on the Kawakita powder compression equation. J Pharm Sci 2009;98(3):1053-63
33. Klevan I, Nordstrom J, Bauer-Brandl A, Alderborn G. On the physical interpretation of the initial bending of a Shapiro-Konopicky-Heckel compression profile. Eur J Pharm Biopharm 2009;71(2):395-401
34. Klevan I, Nordstrom J, Tho I, Alderborn G. A statistical approach to evaluate the potential use of compression parameters for classification of pharmaceutical powder materials. Eur J Pharm Biopharm 2010;75(3):425-35
35. Sinka IC. Modelling powder compaction. KONA 2007;25:4-22
36. Wu CY, Hancock BC, Mills A, et al. Numerical and experimental investigation of capping mechanisms during pharmaceutical tablet compaction. Powder Technol 2008;181:121-9
37. Sinha T, Bharadwaj R, Curtis JS, et al. Finite element analysis of pharmaceutical tablet compaction using a density dependent material plasticity model. Powder Technol 2010;202:46-54
38. Hassanpour A, Ghadiri M. Distinct element analysis and experimental evaluation of the Heckel analysis of bulk powder compression. Powder Technol 2004;141:251-61 (Pubitemid 38726143)
39. Frenning G. An efficient finite/discrete element procedure for simulating compression of 3D particle assemblies. Comput Methods Appl Mech Eng 2008;97:4266-72
40. Frenning G. Compression mechanics of granule beds: a combined finite/discrete element study. Chem Eng Sci 2010;65:2464-71
41. Ahmat N, Ugail H, Gonzalez Castro G. Method of modelling the compaction behaviour of cylindrical pharmaceutical tablets. Int J Pharm 2011;405(1-2):113-21
42. Ugail H, Wilson M. Modelling of oedemous limbs and venous ulcers using partial differential equations. Theor Biol Med Model 2005;2:28
43. Ugail H. Method oftrimming PDE surfaces. Comput Graph 2006;30:225-32
44. Frenning G, Mahmoodi F, Nordstrom J, Alderborn G. An effective-medium analysis of confined compression of granular materials. Powder Technol 2009;194:228-32
45. Bauer-Brandl A, Ritschel WA. Die Tablette: Handbuch der Entwicklung, Herstellung und Qualitatssicherung. 3rd edition. Editio Cantor Verlag; Aulendorf: 2002. p. 94
46. Haware RV, Bauer-Brandl A, Tho I. Comparative evaluation of the powder and compression properties of various grades and brands of microcrystalline cellulose by multivariate methods. Pharm Dev Technol 2010;15(4):394-404
47. Jelcic Z, Hauschild K, Ogiermann M, Picker-Freyer KM. Evaluation of tablet formation of different lactoses by 3D modeling and fractal analysis. Drug Dev Ind Pharm 2007;33(4):353-72 (Pubitemid 46808781)
48. Haware RV, Tho I, Bauer-Brandl A. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for alpha-lactose monohydrates. Eur J Pharm Biopharm 2009;73(3):424-31
49. Gabrielsson J, Lindberg NO, Lundstedt T. Multivariate methods in pharmaceutical applications. J Chemometr 2002;16:141-60
50. Circunay JJN, Plaizier-Vercammen JA. Optimization of a new filler/binder for direct compression using central composite design. Drug Dev Ind Pharm 1997;23(10):945-50 (Pubitemid 27412599)
51. Gabrielsson J, Sjostrom M, Lindberg NO, et al. Multivariate methods in the development of a new tablet formulation: excipient mixtures and principal properties. Drug Dev Ind Pharm 2006;32(1):7-20 (Pubitemid 43220910)
52. Lundstedt-Enkel K, Gabrielsson J. Olsman H, et al. Different multivariate approaches to material discovery, process development, PAT and environmental process monitoring. Chemometr Intell Lab Syst 2006;84:201-7 (Pubitemid 44708408)
53. Andersson M, Ringberg A, Gustafson C. Multivariate methods in tablet formulation suitable for early drug development: predictive models from a screening design of several linked responses. Chemometr Intell Lab Syst 2007;87:125-30
54. Huang J, Kaul G, Cai C, et al. Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm 2009;382(1-2):23-32
55. Ilkka J, Paronen P. Prediction of the compression behavior of powder mixtures by the Heckel equation. Int J Pharm 1993;94:181-7 (Pubitemid 23204064)
56. Zheng JM, Carlson WB, Reed JS. The packing density of binary powder mixtures. J Eur Ceram Soc 1995;15:479-83
57. Busignies V, Leclerc B, Porion P, et al. Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients. Eur J Pharm Biopharm 2006;64(1):66-74 (Pubitemid 44160660)
58. Frenning G, Nordstrom J, Alderborn G. Effective Kawakita parameters for binary mixtures. Powder Technol 2009;189(2):270-5
59. Mazel V, Busignies V, Duca S, et al. Original predictive approach to the compressibility of pharmaceutical powder mixtures based on the Kawakita equation. Int J Pharm 2011;410:92-8
60. Holman LE, Leuenberger H. The relationship between solid fraction and mechanical properties of compacts - the percolation theory model approach. Int J Pharm 1988;46:35-44
61. Blattner D, Kolb M, Leuenberger H. Percolation theory and compactibility of binary powder systems. Pharm Res 1990;7(2):113-17 (Pubitemid 20208061)
62. Leuenberger H, Leu R. Formation of a tablet: a site and bond percolation phenomenon. J Pharm Sci 1992;81(10):976-82 (Pubitemid 23006859)
63. Kimura G, Puchkov M, Betz G, Leuenberger H. Percolation theory and the role of maize starch as a disintegrant for a low water-soluble drug. Pharm Dev Technol 2007;12:11-19 (Pubitemid 46902609)
64. Abdel-Hamid S, Betz G. Study of radial die-wall pressure changes during pharmaceutical powder compaction. Drug Dev Ind Pharm 2011;37(4):387-95
65. Mehrotra A, Llusa M, Faqih A, et al. Influence of shear intensity and total shear on properties of blends and tablets of lactose and cellulose lubricated with magnesium stearate. Int J Pharm 2007;336:284-91 (Pubitemid 46670655)
66. Pingali K, Mendez R, Lewis D, et al. Mixing order of glidant and lubricant -Influence on powder and tablet properties. Int J Pharm 2011;409:269-77
67. Haware RV, Tho I, Bauer-Brandl A. Application of multivariate methods to compression behavior evaluation of directly compressible materials. Eur J Pharm Biopharm 2009;72(1):148-55
68. Wang J, Wen H, Desai D. Lubrication in tablet formulation. Eur J Pharm Biopharm 2010;75:1-15
69. Nordstrom J, Alderborn G. Degree of compression as a potential process control tool of tablet tensile strength. Pharm Dev Technol 2011;published online 22 July 2010; DOI:10.3109/10837450.2010.502177
70. Nystrom C, Alderborn G, Duberg M, Karehill PG. Bonding surface area and bonding mechanism - Two important factors for the understanding of power compactibility. Drug Dev Ind Pharm 1993;19(17-18):2143-96 (Pubitemid 23337892)
71. Emschermann B, Muller F. Auswertung der Kraftmessung beim Tablettieren. Pharm Ind 1981;43:191-4
72. Kala H, Moldenhauer H, Giese R, et al. Polymorphism of sulfathiazole and its crystallographic behavior under compression pressure. Pharmazie 1981;36:833-8 (Pubitemid 12126554)
73. Leitritz M, Krumme M, Schmidt PC Force-time curves of a rotary tablet press. Interpretation of the compressibility of a modified starch containing various amounts of moisture. J Pharm Pharmacol 1996;48:456-62 (Pubitemid 26197151)
74. Yliruusi JK, Merkku P, Hellen L, Antikainen OK. A new method to evaluate the elastic behaviour of tablets during compression. Drug Dev Ind Pharm 1997;23(1):63-8 (Pubitemid 27099480)
75. Yliruusi JK, Antikainen OK. New parameters derived from tablet compression curves. Part I. Force-time curve. Drug Dev Ind Pharm 1997;23(1):69-79 (Pubitemid 27099481)
76. Dietrich R, Mielck JB. Parametrisierung des zeitlichen Verlaufs der Verdichtung bei der Tablettierung mit Hilfe der modifizierten Weibull-Funktion: 1.Mitt.: Gedanklicher und experimenteller Ansatz. Pharm Ind 1984;46:863-9
77. Mielck JB, Stark G. Tabletting of powder mixtures: Parameters of evolved pressure-time profiles indicate percolation thresholds. Eur J Pharm Biopharm 1995;41(4):206-14
78. Fraser RDB, Suzuki E. Resolution of overlapping bands: functions for simulating band shapes. Anal Chem 1969;38:1770
79. Shlieout G, Wiese F, Zessin G. A new method to evaluate the consolidation behavior of pharmaceutical materials by using the Fraser-Suzuki function. Drug Dev Ind Pharm 1999;25(1):29-36 (Pubitemid 29071483)
80. Chilamkurti RN, Rhodes CT, Schwartz JB. Some studies on compression properties of tablet matrices using a computerized instrumented press. Drug Dev Ind Pharm 1982;8:63-86 (Pubitemid 12070499)
81. Hoblitzel JR, Rhodes CT. Preliminary investigations on the parity of tablet compression data obtained from different instrumented tablet presses. Drug Dev Ind Pharm 1986;12:507-25 (Pubitemid 16141988)
82. Heckel RW. Density-pressure relationships in powder compaction. Trans Metall Soc Aime 1961;221:671-5
83. Heckel RW. An analysis of powder compaction phenomena. Trans Metall Soc Aime 1961;221:1001-8
84. Paronen P. Heckel plots as indicators of elastic properties of pharmaceuticals. Drug Dev Ind Pharm 1986;12(11-13):1903-12 (Pubitemid 17178853)
85. Paronen P, Ilkka J. Porosity-pressure functions. In: Alderborn G, Nystrom C, editors. Pharmaceutical powder compaction technology. Marcel Dekker, Inc; New York: 1996. p. 55-75
86. Kawakita K. Some considerations on powder compression equations. Powder Technol 1971;4(2):61-8
87. Patel S, Kaushal AM, Bansal AK. Effect of particle size and compression force on compaction behavior and derived mathematical parameters of compressibility. Pharm Res 2007;24(1):111-24 (Pubitemid 44902576)
88. Kawakita K, Hattori I, Kishigami M. Characteristic constants in Kawakita's powder compression equation. J Powder Bulk Solids Technol 1977;1:3-8 (Pubitemid 8561279)
89. Shapiro I. Compaction of powders-x -development of a general compaction equation. In: Lawley A, Swanson A editors. Advances in powder metallurgy & particulate materials - Modeling, design, and computational methods. Volume 3 Metal Powder Industries Fed; Princeton: 1993. p. 229-43
90. Shapiro I. Compaction ofpowders. 11. Application of the general equation to both metal powders and ceramic powders. In: Lall C, Neupaver AJ, editors. Advances in powder metallurgy & particulate materials - Compaction, sintering and secondary operations. Volume 3 Metal Powder Industries Fed; Princeton: 1994. p. 41-55
91. Picker KM. A new theoretical model to characterize the densification behavior of tableting materials. Eur J Pharm Biopharm 2000;49(3):267-73 (Pubitemid 30229876)
92. Picker-Freyer KM. The 3-D model: experimental testing of the parameters d, e, and omega and validation of the analysis. J Pharm Sci 2007;96(5):1408-17 (Pubitemid 46797498)
93. Cooper AR, Eaton LE. Compaction behaviour of some ceramic powders. J Am Ceramic Soc 1962;45(3):97-101
94. Sonnergaard JM. Investigation of a new mathematical model for compression of pharmaceutical powders. Eur J Pharm Sci 2001;14(2):149-57 (Pubitemid 32737536)
95. Ragnarsson G, Sjoegren J. Work of friction and net work during compaction. J Pharm Pharmacol 1983;35(4):201-4 (Pubitemid 13159799)